Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 938526 | ISIN: FR0000075954 | Ticker-Symbol: RI7
Frankfurt
26.04.24
11:29 Uhr
2,700 Euro
-0,030
-1,10 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RIBER SA Chart 1 Jahr
5-Tage-Chart
RIBER SA 5-Tage-Chart
RealtimeGeldBriefZeit
2,6702,88026.04.
GlobeNewswire (Europe)
670 Leser
Artikel bewerten:
(2)

Riber: 2023 revenues up +41% to €39.2m


2023 revenues up +41% to €39.2m

  • Strong growth in systems revenues: +96%.
  • Order book at end-2023: €26.3 M
  • Outlook for revenues growth in 2024

Bezons (France), January 31, 2024 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment serving the semiconductor industry, is reporting its full-year revenues for 2023.

Change in revenues

€m20232022Change
First quarter3.72.4+55%
Second quarter8.56.8+24%
Third quarter4.03.0+34%
Fourth quarter23.015.6+48%
Full year39.227.8+41%
€m20232022Change
Systems29.014.8+96%
Services and accessories10.313.0-21%
Full year39.227.8+41%

2023 full-year revenues amounted to €39.2m, up 41% from 2022. In the fourth quarter of 2023, revenues growth remained strong at 48%. This impressive growth is the result of RIBER's enhanced market position in MBE systems for production.

MBE systems revenues reached €29.0m, up 96%. 13 MBE systems, including 5 production systems, were delivered over the year, compared with 6 systems, including 4 production systems, in 2022.

Revenues for services and accessories totalled €10.3m, down 21% compared with a high basis of comparison in 2022.

The breakdown of 2023 full-year revenues is as follows: 63% for Asia, 24% for Europe and 13% for North America.

Order book developments

At December 31 (€m)20232022Change
Systems20.224.6-18%
Services and accessories6.15.3+16%
Full year26.329,9-12%


The order book for MBE systems is down 18% to €20.2m, following the major deliveries at the end of 2023. This figure is based on 6 systems, including 5 production systems. This order book includes the order for a production machine in Europe announced on January 8, 2024. It does not incorporate the major order for three production systems in Asia announced on January 24, 2024.

Orders for services and accessories showed improvement, up 16% from the previous year.

At December 31, 2023, the consolidated order book amounted to €26.3m, down -12% from the previous year.

Outlook for 2024

Given the composition of the order book at December 31, 2023, and the outlook for orders to be delivered this year for systems, services and accessories, RIBER is forecasting further growth in 2024 revenues compared with 2023.

Next date

RIBER will release its 2023 full-year earnings on April 12, 2024 (before start of trading).

About RIBER
RIBER is the global market leader for MBE - molecular beam epitaxy - equipment. It designs and produces equipment for the semiconductor industry and provides scientific and technical support for its clients (hardware and software), maintaining their equipment and optimizing their performance and output levels.
Accelerating the performance of electronics, RIBER's equipment performs an essential role in the development of advanced semiconductor systems that are used in numerous applications, from information technologies to photonics (lasers, sensors, etc.), 5G telecommunication networks and research including the field of quantum computing.
RIBER is a BPI France-approved innovative company and is listed on the Euronext Growth Paris market (ISIN: FR0000075954).
www.riber.com

Contacts

RIBER: Annie Geoffroy| Tel: +33 (0)1 39 96 65 00 | invest@riber.com

CALYPTUS: Cyril Combe | tell: +33 (0)1 53 65 68 68 | cyril.combe@calyptus.net


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.